Currently, the diagnosis of dementia relies primarily on neurological and psychological assessment, imaging modalities, and analyses of the cerebrospinal fluid (CSF), especially tau, phosphorylated tau (p-tau), and beta amyloid 1–42 (Aβ42), some of which are specific to AD pathology. This evidence concerns the gene MAPT and Alzheimer disease.